BREKIYA Drug Patent Profile
✉ Email this page to a colleague
When do Brekiya patents expire, and when can generic versions of Brekiya launch?
Brekiya is a drug marketed by Amneal and is included in one NDA. There are eight patents protecting this drug.
The generic ingredient in BREKIYA is dihydroergotamine mesylate. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brekiya
A generic version of BREKIYA was approved as dihydroergotamine mesylate by HIKMA on June 9th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BREKIYA?
- What are the global sales for BREKIYA?
- What is Average Wholesale Price for BREKIYA?
Summary for BREKIYA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| What excipients (inactive ingredients) are in BREKIYA? | BREKIYA excipients list |
| DailyMed Link: | BREKIYA at DailyMed |
US Patents and Regulatory Information for BREKIYA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | BREKIYA (AUTOINJECTOR) | dihydroergotamine mesylate | SOLUTION;SUBCUTANEOUS | 215400-001 | May 14, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal | BREKIYA (AUTOINJECTOR) | dihydroergotamine mesylate | SOLUTION;SUBCUTANEOUS | 215400-001 | May 14, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Amneal | BREKIYA (AUTOINJECTOR) | dihydroergotamine mesylate | SOLUTION;SUBCUTANEOUS | 215400-001 | May 14, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Amneal | BREKIYA (AUTOINJECTOR) | dihydroergotamine mesylate | SOLUTION;SUBCUTANEOUS | 215400-001 | May 14, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Amneal | BREKIYA (AUTOINJECTOR) | dihydroergotamine mesylate | SOLUTION;SUBCUTANEOUS | 215400-001 | May 14, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Amneal | BREKIYA (AUTOINJECTOR) | dihydroergotamine mesylate | SOLUTION;SUBCUTANEOUS | 215400-001 | May 14, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
